We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and a recent National Patient Safety Alert asking organisations to put a plan in place to implement new regulatory measures for valproate.
Ability of the contraceptive progestin levonorgestrel to bind chemically with hydrosilane groups in addition-cure silicone elastomers
Information for those who have been prescribed Paxlovid.
The National Leptospirosis Service (NLS) is the national laboratory reference centre for the diagnosis of leptospira infections.
There is a risk of harmful drug interactions with the ritonavir component of the COVID-19 treatment Paxlovid▼ due to its inhibition of the enzyme CYP3A, which metabolises many commonly used drugs. Prescribers should obtain a detailed patient history of current...
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
A summary of recent letters and notifications sent to healthcare professionals about medicines.
Accord Healthcare Ltd, UK has informed the MHRA about an error with the Patient Information Leaflets (PILs) that have been packaged in the batches of these products mentioned in this notification.
Public Assessment Report on our review of the risks of using haloperidol for the acute treatment of delirium in elderly patients.
Information for patients who have been prescribed Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets COVID-19 antiviral medication.
Product Safety Report for Esapharma Movate Steroid Cream presenting a serious chemical risk.
The information in this leaflet is intended to give guidance for parents/carers whose children have been issued oseltamivir oral solution 15mg in 1ml, which has been specially made for children under 1 year old to treat seasonal flu.
Information for those who have been prescribed Molnupiravir.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).